Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda
- PMID: 37060030
- PMCID: PMC10103467
- DOI: 10.1186/s12879-023-08174-3
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda
Abstract
Background: Combined antiretroviral therapy (cART) dramatically improved survival in people living with HIV (PLWH) but is associated with weight gain (WG), raising concern for a possible obesity epidemic in PLWH. This scoping review aims to identify the gaps in the existing evidence on WG in PLWH and generate a future research agenda.
Methods: This review was conducted according to the methodology for scoping studies and reported according to the PRISMA Extension for Scoping Review checklist. Articles published in English in the last 10 years indexed in Pubmed, WHO Global Index Medicus, or Embase were searched using specific queries focused on WG in PLWH.
Results: Following the selection process, 175 included articles were reviewed to search for the available evidence on four specific topics: (I) definition of WG in PLWH, (II) pathogenesis of WG in PLWH, (III) impact of ART on WG, (IV) correlation of WG with clinical outcomes. A summary of the data enabled us to identify gaps and clearly define the following research agenda: (I) develop a data-driven definition of WG in PLWH and define noninvasive assessment methods for body weight and fat composition; (II) further investigate the interaction between HIV/cART and immunity, metabolism, and adipose tissue; (III) establish the specific role of individual drugs on WG; (IV) clarify the independent role of WG, cART, HIV, and metabolic factors on clinical events.
Conclusions: The proposed research agenda may help define future research and fill the knowledge gaps that have emerged from this review.
Keywords: Antiretroviral therapy; HIV; Research agenda; Weight gain.
© 2023. The Author(s).
Conflict of interest statement
GG has received research grant and speaker honorarium from Gilead, ViiV, MERCK, and Janssen. He attended advisory boards of Gilead, ViiV, and MERCK. LT served as a consultant or attended advisory boards for Janssen, Gilead Sciences, ViiV Healthcare and received research grant by Gilead Sciences. The other authors have nothing to disclose.
Similar articles
-
Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV.HIV Res Clin Pract. 2022 Nov 22;24(1):1-6. HIV Res Clin Pract. 2022. PMID: 36883678
-
The impact of the COVID-19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review.J Int AIDS Soc. 2023 Mar;26(3):e26060. doi: 10.1002/jia2.26060. J Int AIDS Soc. 2023. PMID: 36912238 Free PMC article.
-
Brief communication: body composition and hidden obesity in people living with HIV on antiretroviral therapy.AIDS Res Ther. 2024 Mar 1;21(1):12. doi: 10.1186/s12981-024-00599-3. AIDS Res Ther. 2024. PMID: 38429716 Free PMC article.
-
Characteristics of hypertension among people living with HIV in Ghana: Impact of new hypertension guideline.J Clin Hypertens (Greenwich). 2019 Jun;21(6):838-850. doi: 10.1111/jch.13561. Epub 2019 May 24. J Clin Hypertens (Greenwich). 2019. PMID: 31125188 Free PMC article.
-
Risks of Type 2 diabetes among older people living with HIV: A scoping review.S Afr Fam Pract (2004). 2023 May 23;65(1):e1-e10. doi: 10.4102/safp.v65i1.5623. S Afr Fam Pract (2004). 2023. PMID: 37265137 Free PMC article.
Cited by
-
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France.AIDS. 2025 May 1;39(6):695-700. doi: 10.1097/QAD.0000000000004118. Epub 2025 Jan 20. AIDS. 2025. PMID: 39792273 Free PMC article.
-
Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda.AIDS Res Ther. 2024 Apr 18;21(1):23. doi: 10.1186/s12981-024-00615-6. AIDS Res Ther. 2024. PMID: 38637785 Free PMC article.
-
The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.AIDS. 2024 Jul 15;38(9):1323-1332. doi: 10.1097/QAD.0000000000003903. Epub 2024 Apr 18. AIDS. 2024. PMID: 38597416 Free PMC article.
-
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use.HIV Med. 2025 Jun;26(6):870-878. doi: 10.1111/hiv.70019. Epub 2025 Mar 20. HIV Med. 2025. PMID: 40110671 Free PMC article.
-
Weight gain, obesity, and the impact of lifestyle factors among people living with HIV: A systematic review.Obes Rev. 2025 Jul;26(7):e13908. doi: 10.1111/obr.13908. Epub 2025 Feb 17. Obes Rev. 2025. PMID: 39957406 Free PMC article.
References
-
- Nduka CU, Uthman OA, Kimani PK, Stranges S. Body Fat Changes in People living with HIV on antiretroviral therapy. AIDS Rev. 2016;18(4):198–211. - PubMed